Skip to main content
. 2019 Sep 10;8(15):6709–6716. doi: 10.1002/cam4.2416

Table 4.

Clinical characteristics of patient samples

  N Age, y CA‐125, IU/L
Healthy Controls 15 53 (45‐71) **
Stage I Serous Borderline tumors 17 56 (45‐69) 42 (4.9‐763)
Stage I/II High‐Grade Serous Carcinomas 21 59 (45‐74) 174 (9‐7000)
Stage I/II High‐Grade Endometrioid or Clear Cell Carcinomas 14 59 (48‐78) 300 (25.8‐7005)
Stage III/IV High‐Grade Serous Carcinomas 27 56 (46‐68) 157.3 (31.2‐1889)
Stage III/IV High‐Grade Endometrioid or Clear Cell Carcinomas 8 55.5 (50‐63) 551.65 (58‐3257)

Values represent medians (range).

**

Not applicable.